Such clearance of amyloid plaques or tau tangles has been strikingly demonstrated in animal models [165, 166] and can be detected in humans when PET tracers that bind to the protein aggregate in question are available—currently limited to amyloid and tau in AD. This evidence concerns the gene MAPT and amyloidosis.